
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.
We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.
- “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
by Charles H. Chen and Timothy K. Lu
Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024
- “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087
- “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106
- “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112
- “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566
- “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113
- “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
- “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
- “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
- “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101
- “Postulated Adjuvant Therapeutic Strategies for COVID-19”
by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080
- “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179
- "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095
- “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002
- “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735
- “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140
- “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
Journal of Clinical Medicine | Call for Special Issue Proposals and Recruiting Guest Editors

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal of clinical medicine, published semi-monthly online by MDPI. JCM supports scientific innovations and clinical medicine research within the whole field and its related fields. The journal is indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases. For more details, please see the following link: https://www.mdpi.com/journal/jcm.
The JCM editorial team is pleased to announce this open call for Special Issue proposals, which offers a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We are soliciting high-quality proposals that will be evaluated in a continuous selection process throughout the year.
If you would like to propose a Special Issue topic for this journal, please visit the following link and then complete and submit the form: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm, and contact the JCM Editorial Office (jcm@mdpi.com). Our editors will respond to you as soon as possible.
The duties of Guest Editors are as follows:
- Refining the Special Issue’s title and scope, as well as providing a short introduction (100–200 words) and 5–10 keywords to set up the Special Issue’s website;
- Inviting contributors with the assistance of the in-house editor to achieve a publication target (e.g., 10 papers);
- Supervising the peer review process of the Special Issue, conducting a pre-review check, making final decisions based on at least two review reports that we have collected, etc.
- You will be offered an opportunity to publish one of your papers free of charge in an open access format, in addition to having the chance to provide the waivers to the papers that you invited for your Special Issue;
- A printed book of the Special Issue can be sent to you if more than 10 papers are published by the end of the Special Issue. See more information at https://www.mdpi.com/books;
- It is an ideal venue for networking and communicating with scholars in the research community, as well as a chance to mark you as influential within your discipline. The relationships you develop will last beyond the publication of your Special Issue, establishing a network for future collaboration;
- You can freely organize or promote your own conferences by using our platform SciForum.
The Editorial Office will set up the Special Issue’s website, arrange the promotional materials, assist with the invitations for paper contributions, and take care of the administrative tasks associated with peer review.
Please do not hesitate to contact the Editorial Office (jcm@mdpi.com) for further details and clarification.
We look forward to receiving your proposals.
Journal of Clinical Medicine Editorial Office
28 July 2023
Journal of Clinical Medicine | World Hepatitis Day in 2023—“We’re not waiting”

World Hepatitis Day (WHD), held on 28 July every year, aims to raise global awareness of hepatitis—a group of infectious diseases known as hepatitis A, B, C, D, and E—and encourage prevention, diagnosis, and treatment, where we bring the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2023, the theme is “We’re not waiting”, and we call on people around the world to take action because hepatitis can’t wait.
To further explore the related research on the World Hepatitis Day 2023, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on the topic of hepatitis. We hope to share new scientific knowledge in the field of hepatitis with the world on this special day.
Article Collections:
1. "CD8+ T Cell Responses during HCV Infection and HCC"
by Maike Hofmann, Catrin Tauber, Nina Hensel and Robert Thimme
J. Clin. Med. 2021, 10(5), 991; https://doi.org/10.3390/jcm10050991
2. "Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis"
by Leonardo Frazzoni, Usama Sikandar, Flavio Metelli, Sinan Sadalla, Giuseppe Mazzella, Franco Bazzoli, Lorenzo Fuccio and Francesco Azzaroli
J. Clin. Med. 2021, 10(8), 1694; https://doi.org/10.3390/jcm10081694
3. "Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis"
by Bianca Cerbu, Mirela Loredana Grigoras, Felix Bratosin, Iulia Bogdan, Cosmin Citu, Adrian Vasile Bota, Madalina Timircan, Melania Lavinia Bratu, Mihaela Codrina Levai and Iosif Marincu
J. Clin. Med. 2022, 11(3), 652; https://doi.org/10.3390/jcm11030652
4. "Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis"
by Tom Domovitz and Meital Gal-Tanamy
J. Clin. Med. 2021, 10(3), 551; https://doi.org/10.3390/jcm10030551
5. "Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection"
by Pil Soo Sung and Eui-Cheol Shin
J. Clin. Med. 2021, 10(2), 221; https://doi.org/10.3390/jcm10020221
6. "Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy"
by Jonathan Grimm, Georg Peschel, Martina Müller, Doris Schacherer, Reiner Wiest, Kilian Weigand and Christa Buechler
J. Clin. Med. 2021, 10(8), 1621; https://doi.org/10.3390/jcm10081621
7. "Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis"
by Camelia Gianina Foncea, Ioan Sporea, Raluca Lupușoru, Tudor Voicu Moga, Felix Bende, Roxana Șirli and Alina Popescu
J. Clin. Med. 2021, 10(11), 2338; https://doi.org/10.3390/jcm10112338
8. "Hepatitis C: A Pharmacological Therapeutic Update"
by Sonia Santander Ballestín, David Gómez Martín, Sara Lorente Pérez and María José Luesma Bartolomé
J. Clin. Med. 2021, 10(8), 1568; https://doi.org/10.3390/jcm10081568
9. "Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis"
by Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa et al.
J. Clin. Med. 2021, 10(11), 2465; https://doi.org/10.3390/jcm10112465
10. "Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease"
by Ilkay S. Idilman, Hsien Min Low, Tolga Gidener, Kenneth Philbrick, Taofic Mounajjed, Jiahui Li, Alina M. Allen, Meng Yin and Sudhakar K. Venkatesh
J. Clin. Med. 2021, 10(12), 2565; https://doi.org/10.3390/jcm10122565
11. "Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens"
by Muhammad Nauman Zahid
J. Clin. Med. 2022, 11(3), 770; https://doi.org/10.3390/jcm11030770
12. "Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy"
by Cesare Mazzaro, Luigi Elio Adinolfi, Gabriele Pozzato, Riccardo Nevola, Ada Zanier, Diego Serraino, Pietro Andreone, Roberta Fenoglio, Savino Sciascia, Valter Gattei et al.
J. Clin. Med. 2022, 11(21), 6247; https://doi.org/10.3390/jcm11216247
13. "Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients"
by Hiroteru Kamimura, Hirofumi Nonaka, Masaya Mori, Taichi Kobayashi, Toru Setsu, Kenya Kamimura, Atsunori Tsuchiya and Shuji Terai
J. Clin. Med. 2022, 11(2), 387; https://doi.org/10.3390/jcm11020387
14. "Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System—A Hospital-Based Experience"
by Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Shu-Yi Wang, Ping-Fang Chiu and Hsu-Heng Yen
J. Clin. Med. 2022, 11(2), 423; https://doi.org/10.3390/jcm11020423
15. "Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients"
by Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim and Yeon Seok Seo
J. Clin. Med. 2022, 11(6), 1729; https://doi.org/10.3390/jcm11061729
Access more articles:
https://www.mdpi.com/search?journal=jcm.
Call for Paper:
"Clinical Advances in Viral Hepatitis"
Guest Editor: Prof. Dr. Calvin Q. Pan
Submission Deadline: 30 September 2023
"New Advances in Management of Hepatitis B Virus (HBV) Infection"
Guest Editors: Dr. Maryam Moini and Dr. Scott K. Fung
Submission Deadline: 25 November 2023
Access more Special Issues:
https://www.mdpi.com/journal/jcm/special_issues?section_id=491&search=&sort=deadline&view=open&page_count=100.
Special Issue Book:
“Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
Access more Special Issue books:
https://www.mdpi.com/books/search?type=Reprint%20Book&journal_facet=Journal%20of%20Clinical%20Medicine.
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Endocrinology & Metabolism”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Endocrinology & Metabolism” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Endocrinology & Metabolism" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients"
by Malgorzata Mrugacz, Anna Bryl and Katarzyna Zorena
J. Clin. Med. 2021, 10(3), 458; https://doi.org/10.3390/jcm10030458
Available online: https://www.mdpi.com/2077-0383/10/3/458
2. "The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis"
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Available online: https://www.mdpi.com/2077-0383/11/2/400
3. "Advances in Osteoporotic Bone Tissue Engineering"
by Cosmin Iulian Codrea, Alexa-Maria Croitoru, Cosmin Constantin Baciu, Alina Melinescu, Denisa Ficai, Victor Fruth and Anton Ficai
J. Clin. Med. 2021, 10(2), 253; https://doi.org/10.3390/jcm10020253
Available online: https://www.mdpi.com/2077-0383/10/2/253
4. "Testosterone and Bone Health in Men: A Narrative Review"
by Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono and Atsushi Mizokami
J. Clin. Med. 2021, 10(3), 530; https://doi.org/10.3390/jcm10030530
Available online: https://www.mdpi.com/2077-0383/10/3/530
5. "The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases"
by Alicja Derkacz, Paweł Olczyk, Krystyna Olczyk and Katarzyna Komosinska-Vassev
J. Clin. Med. 2021, 10(5), 1122; https://doi.org/10.3390/jcm10051122
Available online: https://www.mdpi.com/2077-0383/10/5/1122
6. "Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis"
by Xiaoling Li, Nina C. Weber, Danny M. Cohn, Markus W. Hollmann, J. Hans DeVries, Jeroen Hermanides and Benedikt Preckel
J. Clin. Med. 2021, 10(11), 2419; https://doi.org/10.3390/jcm10112419
Available online: https://www.mdpi.com/2077-0383/10/11/2419
7. "Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?"
by Lore Raets, Kaat Beunen and Katrien Benhalima
J. Clin. Med. 2021, 10(6), 1257; https://doi.org/10.3390/jcm10061257
Available online: https://www.mdpi.com/2077-0383/10/6/1257
8. "Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors"
by Agnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, Aleksandra Zoń-Giebel and Katarzyna Komosińska-Vassev
J. Clin. Med. 2021, 10(13), 2905; https://doi.org/10.3390/jcm10132905
Available online: https://www.mdpi.com/2077-0383/10/13/2905
9. "Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases"
by Gerhard Paul Püschel, Julia Klauder and Janin Henkel
J. Clin. Med. 2022, 11(15), 4358; https://doi.org/10.3390/jcm11154358
Available online: https://www.mdpi.com/2077-0383/11/15/4358
10. "The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration—A Narrative Review"
by Laura Rehak, Laura Giurato, Marco Meloni, Andrea Panunzi, Giada Maria Manti and Luigi Uccioli
J. Clin. Med. 2022, 11(3), 889; https://doi.org/10.3390/jcm11030889
Available online: https://www.mdpi.com/2077-0383/11/3/889
11. "Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes"
by Maria Mirabelli, Eusebio Chiefari, Vera Tocci, Patrizia Caroleo, Stefania Giuliano, Emanuela Greco, Raul Miguel Luque, Luigi Puccio, Daniela Patrizia Foti, Antonio Aversa et al.
J. Clin. Med. 2021, 10(5), 985; https://doi.org/10.3390/jcm10050985
Available online: https://www.mdpi.com/2077-0383/10/5/985
12. "Etiology and Diagnosis of Permanent Hypoparathyroidism after Total Thyroidectomy"
by Antonio Sitges-Serra
J. Clin. Med. 2021, 10(3), 543; https://doi.org/10.3390/jcm10030543
Available online: https://www.mdpi.com/2077-0383/10/3/543
13. "The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review"
by Gianmarco Matta-Gutiérrez, Esther García-Morales, Yolanda García-Álvarez, Francisco Javier Álvaro-Afonso, Raúl Juan Molines-Barroso and José Luis Lázaro-Martínez
J. Clin. Med. 2021, 10(9), 1948; https://doi.org/10.3390/jcm10091948
Available online: https://www.mdpi.com/2077-0383/10/9/1948
14. "Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases"
by Pedro Ruiz-Sala and Luis Peña-Quintana
J. Clin. Med. 2021, 10(21), 4855; https://doi.org/10.3390/jcm10214855
Available online: https://www.mdpi.com/2077-0383/10/21/4855
15. "Effect of Physical Activity, Smoking, and Sleep on Telomere Length: A Systematic Review of Observational and Intervention Studies"
by Rocío Barragán, Carolina Ortega-Azorín, Jose V. Sorlí, Eva M. Asensio, Oscar Coltell, Marie-Pierre St-Onge, Olga Portolés and Dolores Corella
J. Clin. Med. 2022, 11(1), 76; https://doi.org/10.3390/jcm11010076
Available online: https://www.mdpi.com/2077-0383/11/1/76
16. "Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management"
by Karel Dandurand, Dalal S. Ali and Aliya A. Khan
J. Clin. Med. 2021, 10(8), 1604; https://doi.org/10.3390/jcm10081604
Available online: https://www.mdpi.com/2077-0383/10/8/1604
17. "MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus"
by Justyna Pordzik, Ceren Eyileten-Postuła, Daniel Jakubik, Pamela Czajka, Anna Nowak, Salvatore De Rosa, Aleksandra Gąsecka, Agnieszka Cieślicka-Kapłon, Piotr Sulikowski, Krzysztof J. Filipiak et al.
J. Clin. Med. 2021, 10(11), 2371; https://doi.org/10.3390/jcm10112371
Available online: https://www.mdpi.com/2077-0383/10/11/2371
18. "Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review"
by Małgorzata Kiluk, Janina Lewkowicz, Dariusz Pawlak and Anna Tankiewicz-Kwedlo
J. Clin. Med. 2021, 10(11), 2484; https://doi.org/10.3390/jcm10112484
Available online: https://www.mdpi.com/2077-0383/10/11/2484
19. "Changes in Body Composition Are Associated with Metabolic Changes and the Risk of Metabolic Syndrome"
by Yun Hwan Oh, Seulggie Choi, Gyeongsil Lee, Joung Sik Son, Kyae Hyung Kim and Sang Min Park
J. Clin. Med. 2021, 10(4), 745; https://doi.org/10.3390/jcm10040745
Available online: https://www.mdpi.com/2077-0383/10/4/745
20. "How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR"
by Clara García-Carro, Ander Vergara, Sheila Bermejo, María A. Azancot, Ana I. Sánchez-Fructuoso, M. Dolores Sánchez de la Nieta, Irene Agraz and María José Soler
J. Clin. Med. 2021, 10(11), 2505; https://doi.org/10.3390/jcm10112505
Available online: https://www.mdpi.com/2077-0383/10/11/2505
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Nephrology & Urology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Nephrology & Urology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Nephrology & Urology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. “Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients”
by Bilgin Osmanodja, Simon Ronicke, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Evelyn Seelow, Johannes Waiser, Bianca Zukunft, Friederike Bachmann et al.
J. Clin. Med. 2022, 11(9), 2565; https://doi.org/10.3390/jcm11092565
Available online: https://www.mdpi.com/2077-0383/11/9/2565
2. “Therapeutic Advances in Diabetic Nephropathy”
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Available online: https://www.mdpi.com/2077-0383/11/2/378
3. “Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania”
by Adrian Vasile Mureșan, Eliza Russu, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Eliza Mihaela Arbănași and Septimiu Toader Voidăzan
J. Clin. Med. 2022, 11(9), 2452; https://doi.org/10.3390/jcm11092452
Available online: https://www.mdpi.com/2077-0383/11/9/2452
4. “IgA Vasculitis and IgA Nephropathy: Same Disease?”
by Evangeline Pillebout
J. Clin. Med. 2021, 10(11), 2310; https://doi.org/10.3390/jcm10112310
Available online: https://www.mdpi.com/2077-0383/10/11/2310
5. “Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin”
by Susanna Campo, Antonio Lacquaniti, Domenico Trombetta, Antonella Smeriglio and Paolo Monardo
J. Clin. Med. 2022, 11(13), 3759; https://doi.org/10.3390/jcm11133759
Available online: https://www.mdpi.com/2077-0383/11/13/3759
6. “Enhanced Recovery after Surgery: History, Key Advancements and Developments in Transplant Surgery”
by Henry John Golder and Vassilios Papalois
J. Clin. Med. 2021, 10(8), 1634; https://doi.org/10.3390/jcm10081634
Available online: https://www.mdpi.com/2077-0383/10/8/1634
7. “Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know”
by Yukako Ohyama, Matthew B. Renfrow, Jan Novak and Kazuo Takahashi
J. Clin. Med. 2021, 10(16), 3467; https://doi.org/10.3390/jcm10163467
Available online: https://www.mdpi.com/2077-0383/10/16/3467
8. “Perirenal Adipose Tissue—Current Knowledge and Future Opportunities”
by Adriana Grigoraș, Raluca Anca Balan, Irina-Draga Căruntu, Simona Eliza Giușcă, Ludmila Lozneanu, Roxana Elena Avadanei, Andreea Rusu, Laura Adriana Riscanu and Cornelia Amalinei
J. Clin. Med. 2021, 10(6), 1291; https://doi.org/10.3390/jcm10061291
Available online: https://www.mdpi.com/2077-0383/10/6/1291
9. “Targeting Oxidative Stress in Septic Acute Kidney Injury: From Theory to Practice”
by Connie P. C. Ow, Anton Trask-Marino, Ashenafi H. Betrie, Roger G. Evans, Clive N. May and Yugeesh R. Lankadeva
J. Clin. Med. 2021, 10(17), 3798; https://doi.org/10.3390/jcm10173798
Available online: https://www.mdpi.com/2077-0383/10/17/3798
10. “Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study”
by Frank-Peter Tillmann, Lars Figiel, Johannes Ricken, Hermann Still, Christoph Korte, Grete Plassmann and Philipp von Landenberg
J. Clin. Med. 2021, 10(21), 5113; https://doi.org/10.3390/jcm10215113
Available online: https://www.mdpi.com/2077-0383/10/21/5113
11. “Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation”
by Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, Markus Pirklbauer, Michael Rudnicki, Gert Mayer and Julia Kerschbaum
J. Clin. Med. 2022, 11(1), 148; https://doi.org/10.3390/jcm11010148
Available online: https://www.mdpi.com/2077-0383/11/1/148
12. “Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review”
by Adrian Martuszewski, Patrycja Paluszkiewicz, Magdalena Król, Mirosław Banasik and Marta Kepinska
J. Clin. Med. 2021, 10(2), 193; https://doi.org/10.3390/jcm10020193
Available online: https://www.mdpi.com/2077-0383/10/2/193
13. “Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis”
by Jeong-Ju Yoo, Hee Bong Shin, Ju Sun Song, Minjung Kim, Jina Yun, Zisun Kim, Yoo Min Lee, Sang Wook Lee, Kwang Woo Lee, Woong bin Kim et al.
J. Clin. Med. 2021, 10(5), 1097; https://doi.org/10.3390/jcm10051097
Available online: https://www.mdpi.com/2077-0383/10/5/1097
14. “Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment”
by Barbora Knoppova, Colin Reily, R. Glenn King, Bruce A. Julian, Jan Novak and Todd J. Green
J. Clin. Med. 2021, 10(19), 4501; https://doi.org/10.3390/jcm10194501
Available online: https://www.mdpi.com/2077-0383/10/19/4501
15. “Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method”
by Anne-Lise Rolland, Anne-Sophie Garnier, Katy Meunier, Guillaume Drablier and Marie Briet
J. Clin. Med. 2021, 10(2), 168; https://doi.org/10.3390/jcm10020168
Available online: https://www.mdpi.com/2077-0383/10/2/168
16. “Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic”
by Samuel N. Heyman, Thomas Walther and Zaid Abassi
J. Clin. Med. 2021, 10(6), 1200; https://doi.org/10.3390/jcm10061200
Available online: https://www.mdpi.com/2077-0383/10/6/1200
17. “Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Thi Thuy Uyen Nguyen, Hyeong Wan Kim and Won Kim
J. Clin. Med. 2021, 10(19), 4456; https://doi.org/10.3390/jcm10194456
Available online: https://www.mdpi.com/2077-0383/10/19/4456
18. “A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques”
by Natalia Warmuzińska, Kamil Łuczykowski and Barbara Bojko
J. Clin. Med. 2022, 11(3), 487; https://doi.org/10.3390/jcm11030487
Available online: https://www.mdpi.com/2077-0383/11/3/487
19. “Nomograms in Urologic Oncology: Lights and Shadows”
by Alessandro Morlacco, Daniele Modonutti, Giovanni Motterle, Francesca Martino, Fabrizio Dal Moro and Giacomo Novara
J. Clin. Med. 2021, 10(5), 980; https://doi.org/10.3390/jcm10050980
Available online: https://www.mdpi.com/2077-0383/10/5/980
20. “Podocyte Autophagy in Homeostasis and Disease”
by Qisheng Lin, Khadija Banu, Zhaohui Ni, Jeremy S. Leventhal and Madhav C. Menon
J. Clin. Med. 2021, 10(6), 1184; https://doi.org/10.3390/jcm10061184
Available online: https://www.mdpi.com/2077-0383/10/6/1184
27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Peer Review Reports
Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.
MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.
Start and Growth of Open Peer Review at MDPI
The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.
As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.
Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.
Benefits of Open Peer Review
The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.
As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.
Impactful Research
MDPI Papers Cited in the News – IJERPH edition
Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.
During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.
Highly Cited Journal Publications
IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:
- International Journal of Environmental Research and Public Health: 3509 mentions
- Nutrients: 2698 mentions
- International Journal of Molecular Sciences: 1701 mentions
- Journal of Clinical Medicine: 1131 mentions
- Viruses: 1111 mentions
These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.
Example of Recent Mentions
During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:
The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper: “Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments”
Harvard Business Review: “How to Take Better Breaks at Work, According to Research”
IJERPH paper: “Canine-Assisted Therapy Improves Well-Being in Nurses”
National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way”
IJERPH paper: “Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease”
Inside MDPI
MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process
At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.
Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.
To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.
The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.
In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.
Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.
Read more:
Coming Together for Science
The Future of IJERPH
On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.
While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.
Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.
Journal Achievements
In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:
- Founded by Prof. Dr. Paul B. Tchounwou in 2004
- Indexed in PubMed in 2008
- Received its first Impact Factor in 2012
- Published its 5000th paper in 2017
- Over 60,000 papers published as at June 30, 2023
- 131,628,173 paper views in 2018–2022
- Over 28,000 mentions in prominent news outlets
- 17,000 papers cited 10 times or more as at June 30, 2023
- No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
- Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.
These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.
Closing Thoughts
MDPI’s Impact in Spain
During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.
Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.
The Numbers
Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).
Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.
Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.
Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.
Testimonials
I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:
Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)
Chief Executive Officer
MDPI AG
19 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Cardiology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Cardiology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Cardiology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Epidemiological Impact of Myocarditis"
by Ainoosh Golpour, Dimitri Patriki, Paul J. Hanson, Bruce McManus and Bettina Heidecker
J. Clin. Med. 2021, 10(4), 603; https://doi.org/10.3390/jcm10040603
Available online: https://www.mdpi.com/2077-0383/10/4/603
2. "Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity"
by Andreea-Luciana Buicu, Simona Cernea, Imre Benedek, Corneliu-Florin Buicu and Theodora Benedek
J. Clin. Med. 2021, 10(8), 1545; https://doi.org/10.3390/jcm10081545
Available online: https://www.mdpi.com/2077-0383/10/8/1545
3. "Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19"
by Maura M. Zylla, Uta Merle, Johannes A. Vey, Grigorios Korosoglou, Eva Hofmann, Michael Müller, Felix Herth, Werner Schmidt, Erwin Blessing, Christoph Göggelmann et al.
J. Clin. Med. 2021, 10(1), 133; https://doi.org/10.3390/jcm10010133
Available online: https://www.mdpi.com/2077-0383/10/1/133
4. "A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation"
by Grażyna Sygitowicz, Agata Maciejak-Jastrzębska and Dariusz Sitkiewicz
J. Clin. Med. 2021, 10(19), 4430; https://doi.org/10.3390/jcm10194430
Available online: https://www.mdpi.com/2077-0383/10/19/4430
5. "Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device"
by Giuseppe Boriani, Pietro Palmisano, Vincenzo Livio Malavasi, Elisa Fantecchi, Marco Vitolo, Niccolo’ Bonini, Jacopo F. Imberti, Anna Chiara Valenti, Renate B. Schnabel and Ben Freedman
J. Clin. Med. 2021, 10(4), 729; https://doi.org/10.3390/jcm10040729
Available online: https://www.mdpi.com/2077-0383/10/4/729
6. "Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology"
by Gaia Cattadori, Silvia Di Marco, Massimo Baravelli, Anna Picozzi and Giuseppe Ambrosio
J. Clin. Med. 2022, 11(8), 2228; https://doi.org/10.3390/jcm11082228
Available online: https://www.mdpi.com/2077-0383/11/8/2228
7. "Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes"
by Klara Komici, Antonio Bianco, Fabio Perrotta, Antonio Dello Iacono, Leonardo Bencivenga, Vito D'Agnano, Aldo Rocca, Andrea Bianco, Giuseppe Rengo and Germano Guerra
J. Clin. Med. 2021, 10(14), 3053; https://doi.org/10.3390/jcm10143053
Available online: https://www.mdpi.com/2077-0383/10/14/3053
8. "Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)"
by Massimiliano Maines, Pietro Palmisano, Maurizio Del Greco, Donato Melissano, Silvana De Bonis, Stella Baccillieri, Gabriele Zanotto, Antonio D’Onofrio, Renato Pietro Ricci, Roberto De Ponti et al.
J. Clin. Med. 2021, 10(18), 4086; https://doi.org/10.3390/jcm10184086
Available online: https://www.mdpi.com/2077-0383/10/18/4086
9. "The Role of Uric Acid in Acute and Chronic Coronary Syndromes"
by Alessandro Maloberti, Marco Biolcati, Giacomo Ruzzenenti, Valentina Giani, Filippo Leidi, Massimiliano Monticelli, Michela Algeri, Sara Scarpellini, Stefano Nava, Francesco Soriano et al.
J. Clin. Med. 2021, 10(20), 4750; https://doi.org/10.3390/jcm10204750
Available online: https://www.mdpi.com/2077-0383/10/20/4750
10. "Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation"
by Francesco Giallauria, Anna Di Lorenzo, Elio Venturini, Mario Pacileo, Antonello D’Andrea, Umberto Garofalo, Felice De Lucia, Crescenzo Testa, Gianluigi Cuomo, Gabriella Iannuzzo et al.
J. Clin. Med. 2021, 10(8), 1696; https://doi.org/10.3390/jcm10081696
Available online: https://www.mdpi.com/2077-0383/10/8/1696
11. "Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients"
by Anna Kabłak-Ziembicka and Tadeusz Przewłocki
J. Clin. Med. 2021, 10(20), 4628; https://doi.org/10.3390/jcm10204628
Available online: https://www.mdpi.com/2077-0383/10/20/4628
12. "Validation of Noninvasive Remote Dielectric Sensing System to Quantify Lung Fluid Levels"
by Teruhiko Imamura, Wataru Gonoi, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Ryuichi Ushijima et al.
J. Clin. Med. 2022, 11(1), 164; https://doi.org/10.3390/jcm11010164
Available online: https://www.mdpi.com/2077-0383/11/1/164
13. "Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes"
by Michał Ząbczyk, Joanna Natorska and Anetta Undas
J. Clin. Med. 2021, 10(13), 2999; https://doi.org/10.3390/jcm10132999
Available online: https://www.mdpi.com/2077-0383/10/13/2999
14. "Diabetes Mellitus and Heart Failure"
by Filippos Triposkiadis, Andrew Xanthopoulos, Alexandra Bargiota, Takeshi Kitai, Niki Katsiki, Dimitrios Farmakis, John Skoularigis, Randall C. Starling and Efstathios Iliodromitis
J. Clin. Med. 2021, 10(16), 3682; https://doi.org/10.3390/jcm10163682
Available online: https://www.mdpi.com/2077-0383/10/16/3682
15. "Acute Coronary Syndrome in the Older Patient"
by Sergio García-Blas, Alberto Cordero, Pablo Diez-Villanueva, Maria Martinez-Avial, Ana Ayesta, Albert Ariza-Solé, Gemma Mateus-Porta, Manuel Martínez-Sellés, David Escribano, Ana Gabaldon-Perez et al.
J. Clin. Med. 2021, 10(18), 4132; https://doi.org/10.3390/jcm10184132
Available online: https://www.mdpi.com/2077-0383/10/18/4132
16. "Association between Lung Fluid Levels Estimated by Remote Dielectric Sensing Values and Invasive Hemodynamic Measurements"
by Teruhiko Imamura, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Mitsuo Sobajima, Nobuyuki Fukuda et al.
J. Clin. Med. 2022, 11(5), 1208; https://doi.org/10.3390/jcm11051208
Available online: https://www.mdpi.com/2077-0383/11/5/1208
17. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis"
by Francesco Santoro, Adriana Mallardi, Alessandra Leopizzi, Enrica Vitale, Elias Rawish, Thomas Stiermaier, Ingo Eitel and Natale D. Brunetti
J. Clin. Med. 2021, 10(3), 468; https://doi.org/10.3390/jcm10030468
Available online: https://www.mdpi.com/2077-0383/10/3/468
18. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1—Pathophysiology and Diagnosis"
by Elias Rawish, Thomas Stiermaier, Francesco Santoro, Natale D. Brunetti and Ingo Eitel
J. Clin. Med. 2021, 10(3), 479; https://doi.org/10.3390/jcm10030479
Available online: https://www.mdpi.com/2077-0383/10/3/479
19. "Coronary Microvascular Dysfunction: PET, CMR and CT Assessment"
by Elisabetta Tonet, Graziella Pompei, Evelina Faragasso, Alberto Cossu, Rita Pavasini, Giulia Passarini, Matteo Tebaldi and Gianluca Campo
J. Clin. Med. 2021, 10(9), 1848; https://doi.org/10.3390/jcm10091848
Available online: https://www.mdpi.com/2077-0383/10/9/1848
20. "Radiological Cardiothoracic Ratio in Evidence-Based Medicine"
by Krystian Truszkiewicz, Rafał Poręba and Paweł Gać
J. Clin. Med. 2021, 10(9), 2016; https://doi.org/10.3390/jcm10092016
Available online: https://www.mdpi.com/2077-0383/10/9/2016
11 July 2023
MDPI’s Newly Launched Journals in June 2023
With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.
The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.
Please feel free to browse and discover more about the new journals below.
Journal | Founding Editor-in-Chief | Journal topics (selected) |
![]() |
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue | growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article |
![]() |
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue | DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article |
![]() |
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue | lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article |
![]() |
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue | multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article |
![]() |
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue | Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.
4 July 2023
Journal of Clinical Medicine Webinar | Geriatric Surgery: State of the Art, Held on 13 July 2023

On 13 July 2023, MDPI and the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) organized the webinar titled Geriatric Surgery: State of the Art.
The webinar provided a comprehensive overview of the current advancements and best practices in the field of geriatric surgery. The webinar was designed to address the unique challenges and considerations involved in surgical interventions for older adults, who are often faced with complex medical conditions and age-related physiological changes, including frailty and futility. Participants gained a deeper understanding of how to implement evidence-based practices to improve outcomes in this vulnerable patient population.
You can watch the recorded webinar at the following link: https://www.youtube.com/watch?v=vKnbDPDMyBw.
Webinar Chairs and Keynote Speakers:
- Prof. Dr. Fausto Catena (Chair), Department of General and Emergency Surgery, “M. Bufalini” Hospital, Cesena, Italy;
- Dr. Belinda De Simone (Co-Chair), 1Department of General minimally invasive surgery, Guastalla Hospital, AUSL Reggio Emilia, Reggio Emilia, Italy; 2Unit of general and bariatric surgery, Clinique St Louis, Poissy, France;
- Dr. Brian Tian, 1Department of General Surgery, Singapore General Hospital, Singapore; 2Division of Surgical Oncology, National Cancer Centre Singapore, Singapore;
- Dr. Carlo Vallicelli, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy;
- Dr. Raffaele Bova, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy.
Relevant Special Issue:
“Geriatric Surgery: State of the Art”
Guest Editor: Prof. Dr. Fausto Catena
3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
The Future is Open, and MDPI is Leading the Way
I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.
1 Million Published Articles
2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.
Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.
Liberating Science
As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.
In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:
"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”
Impactful Research
MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases
MDPI journals are indexed in every single top database in the world.
As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.
Continued Growth of MDPI Journals
The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.
Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.
Read more
Inside MDPI
Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science
At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.
Increased Visibility for Preprints
I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.
Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.
Read more
What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?
Coming Together for Science
The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications
In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.
Working Together
Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.
Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.
Managing Events With Sciforum
If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!
Read more
Closing Thoughts
Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang
Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team
During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.
I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.
Testimonials
If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:
“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
– Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet
Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection
Chief Executive Officer
MDPI AG